Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

Correction for Chin and Rubin, J Am Coll Cardiol 51 (16) 1527-1538.
J Am Coll Cardiol, 2008; 52:169, doi:10.1016/j.jacc.2008.05.005
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

Correction

Chin KM, Rubin LJ. Pulmonary Arterial Hypertension. J Am Coll Cardiol 2008;51:1527–38.

In Figure 2 of this article, the treatment algorithm for pulmonary arterial hypertension (PAH) adapted from the ACCP guidelines should have listed subcutaneous treprostinil for functional class III PAH as having received a level "B" rather than level "C" strength of recommendation. The corrected figure is printed below. The authors apologize for this error.


Figure 1
View larger version (63K):
[in this window]
[in a new window]
[Download PPT slide]
 
 





This Article
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement